"Lots of companies who have business plans like STSI, trade OTC with market caps well below the almost 150 million that STSI currently has." Correct, HOWEVER none of them has anything remotely comparable to the potential of Anatabine. AS you will learn in due time.
It now is all about the future and the potential of treating many different indications.